Your search returned 105 studies. (Get alerts for new studies):
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Rapid City, South Dakota
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
Location: Rapid City, South Dakota
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Rapid City, South Dakota
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
Location: Rapid City, South Dakota
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Rapid City, South Dakota
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Rapid City, South Dakota
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: Rapid City, South Dakota
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Rapid City, South Dakota
- Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
Conditions: Metastatic Cancer - Pain
Location: Rapid City, South Dakota
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Rapid City, South Dakota
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Rapid City, South Dakota
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Rapid City, South Dakota
- Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Rapid City, South Dakota
- Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors - Neurotoxicity
Location: Rapid City, South Dakota
- Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer Afte
Conditions: Cervical Cancer
Location: Rapid City, South Dakota
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Rapid City, South Dakota
- Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Rapid City, South Dakota
- Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Conditions: Diabetic Macular Edema
Location: Rapid City, South Dakota
- Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Conditions: Breast Cancer
Location: Rapid City, South Dakota
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Rapid City, South Dakota
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Rapid City, South Dakota
- A Study to Determine if There is a Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) and Phosphodiesterase Type 5 (
Conditions: Nonarteritic Anterior Ischemic Optic Neuropathy
Location: Rapid City, South Dakota
- Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Conditions: Light Chain Deposition Disease - Smoldering Multiple Myeloma
Location: Rapid City, South Dakota
- Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
Conditions: Head and Neck Cancer
Location: Rapid City, South Dakota
- Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Rapid City, South Dakota
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Rapid City, South Dakota
- A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Pati
Conditions: Stable Atherothrombotic Disease
Location: Rapid City, South Dakota
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: Rapid City, South Dakota
- Oxycodone DETERx™ Versus Placebo in CLBP
Conditions: Chronic Low Back Pain
Location: Rapid City, South Dakota
- Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment
Conditions: Submacular Vascularized Pigment Epithelial Detachments
Location: Rapid City, South Dakota
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Rapid City, South Dakota
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Rapid City, South Dakota
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Rapid City, South Dakota
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Rapid City, South Dakota
- ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
Conditions: Neoplasms, Breast - Breast Cancer
Location: Rapid City, South Dakota
- Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Prima
Conditions: Brenner Tumor - Fallopian Tube Cancer - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated A
Location: Rapid City, South Dakota
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
Location: Rapid City, South Dakota
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Rapid City, South Dakota
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: Rapid City, South Dakota
- Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Location: Rapid City, South Dakota
- Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Location: Rapid City, South Dakota
- Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
Conditions: Brain and Central Nervous System Tumors
Location: Rapid City, South Dakota
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Rapid City, South Dakota
- Longitudinal Surveillance Registry (LSR) of ACUITY Spiral
Conditions: Heart Failure
Location: Rapid City, South Dakota
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
Location: Rapid City, South Dakota
- Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors
Location: Rapid City, South Dakota
- Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: Rapid City, South Dakota
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Cape
Conditions: Adenocarcinoma of the Pancreas - Stage I Pancreatic Cancer - Stage II Pancreatic Cancer
Location: Rapid City, South Dakota
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Localized Unresectable Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
Location: Rapid City, South Dakota
- Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Rapid City, South Dakota
- This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
Conditions: Heart Failure With Reduced Ejection Fraction
Location: Rapid City, South Dakota
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Rapid City, South Dakota
- Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma
Location: Rapid City, South Dakota
- Patient Registry Study of Berinert® in Normal Clinical Practice
Conditions: Includes: Hereditary Angioedema
Location: Rapid City, South Dakota
- PRE-DETERMINE Cohort Study
Conditions: Coronary Artery Disease - Left Ventricular Dysfunction - Sudden Cardiac Death
Location: Rapid City, South Dakota
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Rapid City, South Dakota
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Rapid City, South Dakota
- A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Conditions: Psoriasis
Location: Rapid City, South Dakota
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: Rapid City, South Dakota
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Conditions: Diarrhea - Gastrointestinal Complications - Unspecified Adult Solid Tumor, Protocol Specific
Location: Rapid City, South Dakota
- Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment o
Conditions: Influenza
Location: Rapid City, South Dakota
- A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001 AM2)
Conditions: Clostridium Difficile Infection
Location: Rapid City, South Dakota
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-re
Conditions: Herpes Zoster
Location: Rapid City, South Dakota
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Rapid City, South Dakota
- Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma
Conditions: Non-Hodgkins Lymphoma
Location: Rapid City, South Dakota
- SuperNOVA Clinical Stenting Trial
Conditions: Atherosclerosis of Native Arteries of the Extremities, Unspecified
Location: Rapid City, South Dakota
- Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
Conditions: Influenza, Human
Location: Rapid City, South Dakota
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Rapid City, South Dakota
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: Rapid City, South Dakota
- Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
Conditions: Cognitive/Functional Effects - Metastatic Cancer - Neurotoxicity - Radiation Toxicity - Unspecified Adult Solid Tumor, Protocol Specific
Location: Rapid City, South Dakota
- Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Conditions: Exudative Age-related Macular Degeneration
Location: Rapid City, South Dakota
- A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opi
Conditions: Low Back Pain
Location: Rapid City, South Dakota
- Open Label Study of Long Term Evaluation Against LDL-C Trial
Conditions: Hypercholesterolemia
Location: Rapid City, South Dakota
- Open Label Study of Long Term Evaluation Against LDL-C Trial
Conditions: Hypercholesterolemia
Location: Rapid City, South Dakota
- Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
Conditions: Breast Cancer - Cancer Survivor - Hot Flashes
Location: Rapid City, South Dakota
- Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Conditions: Coronary Artery Disease - Angina Pectoris
Location: Rapid City, South Dakota
- A Multi-Center, Randomized, Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal
Conditions: Keratoconus - Corneal Ectasia
Location: Rapid City, South Dakota
- A Multi-Center, Randomized, Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal
Conditions: Keratoconus - Corneal Ectasia
Location: Rapid City, South Dakota
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
Location: Rapid City, South Dakota
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Rapid City, South Dakota
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Rapid City, South Dakota
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Rapid City, South Dakota
- Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain
Conditions: Chronic Low Back Pain
Location: Rapid City, South Dakota
- Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Conditions: Clear Cell Renal Cell Carcinoma - Stage IV Renal Cell Cancer
Location: Rapid City, South Dakota
- PROMUS Element Plus US Post-Approval Study
Conditions: Coronary Artery Disease
Location: Rapid City, South Dakota
- Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumor
Conditions: Adult Anaplastic Oligodendroglioma - Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma - Adult Oligodendroglioma - Recurrent Adult Brain Tumor
Location: Rapid City, South Dakota
- Erlotinib With or Without Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer With EGFR Mutations
Conditions: Stage IV Non-small Cell Lung Cancer
Location: Rapid City, South Dakota
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Ag
Conditions: Measles, Mumps and Rubella Diseases
Location: Rapid City, South Dakota
- Efficacy Study to Evaluate EN3409 in Opioid-naive Subjects
Conditions: Low Back Pain
Location: Rapid City, South Dakota
- Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Typ
Conditions: Diabetes Type 2
Location: Rapid City, South Dakota
- Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With SAR236553 (REGN727) (ODYSSEY Outcomes)
Conditions: Acute Coronary Syndrome
Location: Rapid City, South Dakota
- Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrill
Conditions: Atrial Fibrillation
Location: Rapid City, South Dakota
- Efficacy Study to Evaluate EN3409 in Opioid-Experienced Subjects
Conditions: Low Back Pain
Location: Rapid City, South Dakota
- A Study of Evacetrapib in High-Risk Vascular Disease
Conditions: Cardiovascular Diseases
Location: Rapid City, South Dakota
- A Study to Evaluate the Efficacy and Safety of Subcutaneous SCH 900222/MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participa
Conditions: Plaque Psoriasis
Location: Rapid City, South Dakota
- Long-term Open-Label Safety Study to Evaluate EN3409
Conditions: Low Back Pain - Osteoarthritis - Neuropathic Pain
Location: Rapid City, South Dakota
- Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pne
Conditions: Community-acquired Bacterial Pneumonia
Location: Rapid City, South Dakota
- Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2
Conditions: Hyperlipidemia
Location: Rapid City, South Dakota
- LDL-C Assessment w/ PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2
Conditions: Hyperlipidemia
Location: Rapid City, South Dakota
- Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Conditions: Dyslipidemia
Location: Rapid City, South Dakota
- Secukinumab Efficacy and Safety Study in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-TNFα Agents.
Conditions: Rheumatoid Arthritis
Location: Rapid City, South Dakota
- Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Su
Conditions: Childhood Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer - Type 1 Papillary Renal Cell Carcinoma - Type 2 Papillary Renal Cell Carcinoma
Location: Rapid City, South Dakota
- Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil i
Conditions: Hypertension
Location: Rapid City, South Dakota
- Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients
Conditions: Coronary Artery Disease
Location: Rapid City, South Dakota
- Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Conditions: Hyperlipidemia and Mixed Dyslipidemia
Location: Rapid City, South Dakota
|